These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7268827)

  • 1. Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations.
    Uden DL; Miller KW; Strand LM; Johnson PB; Zaske DE
    Ther Drug Monit; 1981; 3(2):143-50. PubMed ID: 7268827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring serum theophylline levels in children. Use of saliva for prediction].
    Dolezalová K; Martínková J; Kopecká J; Kuralová Z; Etlerová E
    Cesk Pediatr; 1989 Oct; 44(10):592-6. PubMed ID: 2620353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP; Meyer UA
    Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unpredictability of theophylline saliva measurements in chronic obstructive pulmonary disease.
    Hendeles L; Burkey S; Bighley L; Richardson R
    J Allergy Clin Immunol; 1977 Dec; 60(6):335-8. PubMed ID: 925259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and predictive value of salivary theophylline levels.
    Jaber M; Schneider AT; Goldstein S; Sergiou H; Bjornson L; Chiaramonte LT
    Ann Allergy; 1987 Feb; 58(2):105-8. PubMed ID: 3813126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetic analysis of theophylline in serum and saliva.
    Trnavská Z; Rejholec V; Elis J; Spicák V
    Int J Clin Pharmacol Res; 1987; 7(5):329-35. PubMed ID: 3667005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring children on sustained-release therapy by salivary theophylline levels.
    Kelly HW; Hadley WM; Murphy SA; Skipper BG
    Am J Dis Child; 1981 Feb; 135(2):137-9. PubMed ID: 7468545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary theophylline monitoring in asthmatic children.
    Orłowski L; Paczkowski D; Podleśny J
    Pol J Pharmacol Pharm; 1987; 39(2):173-6. PubMed ID: 3432165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of theophylline in saliva, using fluorescence polarization immunoassay (FPIA).
    Niemann A; Oellerich M; Schumann G; Sybrecht GW
    J Clin Chem Clin Biochem; 1985 Nov; 23(11):725-32. PubMed ID: 3910758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids.
    Jusko WJ; Poliszczuk A
    Am J Hosp Pharm; 1976 Nov; 33(11):1193-6. PubMed ID: 998637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma.
    Aviram M; Tal A; Ben-Zvi Z; Gorodischer R
    Pediatrics; 1987 Dec; 80(6):894-7. PubMed ID: 3684402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations.
    Boner AL; Valletta EA; Plebani M; Biancotto R; Bellanti JA
    Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of saliva for monitoring theophylline concentrations.
    Rylance GW; Beswick DT; Cullen RE; Roberts DG
    Arch Dis Child; 1985 Jan; 60(1):66-8. PubMed ID: 3970575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and sensitive method for determination of theophylline in plasma and saliva by high pressure liquid chromatography.
    Peng GW; Smith V; Peng A; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):341-50. PubMed ID: 981789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of theophylline bioavailability using saliva theophylline concentrations.
    Uden DL; Strand LM; Miller KW; Zaske DE
    Pharmacotherapy; 1983; 3(4):235-8. PubMed ID: 6889140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods for determining unbound theophylline concentrations.
    Stoehr GP; Venkataramanan R; Dauber JH
    Ther Drug Monit; 1986; 8(1):42-6. PubMed ID: 3515639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship of the theophylline concentration in the saliva and the blood serum in patients with a broncho-obstructive syndrome].
    Tsoĭ AN; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1994; 66(8):42-4. PubMed ID: 7985153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of two methods of determining plasma and salivary theophylline].
    Sallans F; Rodriguez F; Michaud P; Lepargneur JP
    Pathol Biol (Paris); 1988 Feb; 36(2):149-53. PubMed ID: 3279383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of theophylline saliva levels in neonates.
    Toback JW; Gal P; Erkan NV; Roop C; Robinson H
    Ther Drug Monit; 1983 Jun; 5(2):185-9. PubMed ID: 6879643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.